Chungcheongbuk-Do, South Korea

Tae Gyu Nam

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae Gyu Nam. Retrieved from https://idiyas.com/inventor/tae-gyu-nam-a61ht4hm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tae Gyu Nam

Introduction

Tae Gyu Nam is a notable inventor based in Chungchongbuk-do, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of cognitive disorders. With a focus on innovative solutions, he has been awarded a total of 2 patents for his groundbreaking work.

Latest Patents

His latest patents include medicines for treating dementia or cognitive disorders, which comprise asiatic acid derivatives. One of his notable inventions is the use of 2-oxoasiatic acid in the treatment of dementia or cognitive disorders. Additionally, he has developed asiatic acid derivatives having modified A-ring, showcasing his commitment to advancing medical science.

Career Highlights

Tae Gyu Nam is currently associated with Dongkook Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a dedication to improving the quality of life for individuals suffering from cognitive impairments.

Collaborations

He has collaborated with esteemed colleagues such as Sang Sup Jew and Hyeung Geun Park, further enhancing the impact of his research and inventions.

Conclusion

Tae Gyu Nam's contributions to the field of medicine through his innovative patents highlight his role as a leading inventor in the treatment of cognitive disorders. His work not only reflects his expertise but also his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…